The Canada drug delivery market is projected to attain a market size of US$27.431 billion by 2027.
The Canada drug delivery market is one of the leading sectors that's showing drastic growth in the Canadian commercial market. The steady and progressive growth of the medical and pharmaceutical industries is giving potential to the market growth of the Canada drug delivery market. The growth of the medical and pharmaceutical sectors is one of the major driving factors that account for the growth of the Canada drug delivery market. The rising number of chronic diseases and lifestyle diseases in Canada is also increasing the demand for drugs in the market, making to the growth of the Canada drug delivery market. The rising aging population in the country is one of the major factors that account for the need for more drug consumption for medication. The aged population is mostly affected by chronic diseases compared to the younger generation, leading to the need for more medication and medical drugs for the aging population. The increasing number of people above 60 or 65 years of age is rising the demand for medicinal drugs in Canada, contributing to the growth of the Canada drug delivery market.
The recent outbreak of the COVID-19 pandemic had severely affected the Canada drug delivery market. The spread of the COVID-19 pandemic had resulted in the higher consumption of medicines and medicinal drugs in Canada. The lockdowns and isolations imposed by the Canadian government as a prevention to the rising COVID cases had adversely affected the market growth of the Canada drug delivery market. The availability of medicinal drugs reaching people has reduced due to the lockdowns and isolations. The shutdown of non-governmental, pharmaceutical and medicinal production plants also resulted in the less availability of medicinal drugs in the market. The isolations and lockdowns also tampered with the supply chain sector of the drug delivery market resulting in less export and import rate of drugs outside and inside the country. The COVID outbreak had adversely resulted in the decline of the Canada drug delivery market.
Rising number of chronic and lifestyle diseases
The rising number of chronic and lifestyle diseases in Canada is accounting for the growth of the Canada drug delivery market. According to the data of PHAC (Public Health Agency of Canada) approximately about 8.8% of Canadian citizens are affected by diabetes. Diabetes is reported as one of the rising lifestyle diseases recorded in Canada. The PHA of Canada states about 594 new cases of diabetes are reported in Canada every day. The rising number of lifestyle diseases like diabetes is accounting for the growth of the Canada drug delivery market. The lifestyle problems and processed food culture followed by the people of Canada are leading to the rising number of lifestyle diseases in Canada. The increasing number of diseases and the need for medication is leading to more demand for medicinal drugs in the market. The rising percentage of chronic diseases and lifestyle diseases are one of the major factors driving the growth of the Canada drug delivery market.
An increasing number of aged people
The rising aged population is one of the major factors driving the market growth of the Canada drug delivery market. The medication services and medicinal drugs are mostly consumed by the aged section in every country. People above 60+ years of age are more likely to be prone to the diseases compared to younger ages. The increasing number of aged people in a country will also lead to more consumption of medicinal drugs and medicine consumption in that country or region. The rising number of aged people in Canada and their medicinal drug consumption is accounting for the market growth of the Canada drug delivery market.
| Report Metric | Details |
| Market size value in 2027 | US$27.431 billion |
| Growth Rate | CAGR of during the forecast period |
| Base year | 2020 |
| Forecast period | 2022–2027 |
| Forecast Unit (Value) | USD Billion |
| Segments covered | Type, And Application |
| Companies covered | Medtronic, ASTRAZENECA CANADA INC., Henkel Corporation, Becton Dickinson Canada Inc., Boston Scientific Corporation |
| Customization scope | Free report customization with purchase |
Segmentation
Medtronic
ASTRAZENECA CANADA INC.
Henkel Corporation
Becton Dickinson Canada Inc.
Boston Scientific Corporation
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.